These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20418027)

  • 21. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
    Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated weekly replanning for intensity-modulated radiotherapy of cervix cancer.
    Stewart J; Lim K; Kelly V; Xie J; Brock KK; Moseley J; Cho YB; Fyles A; Lundin A; Rehbinder H; Löf J; Jaffray D; Milosevic M
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):350-8. PubMed ID: 20832664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy.
    Sheng K; Molloy JA; Read PW
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):917-23. PubMed ID: 16751074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
    Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
    Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of radiation techniques in treatment of oropharynx cancer.
    Rusthoven KE; Raben D; Ballonoff A; Kane M; Song JI; Chen C
    Laryngoscope; 2008 Apr; 118(4):635-9. PubMed ID: 18176348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer.
    Yamic F; Koca T; Tuncel N; Aksoy RA; Korcum AF
    Technol Cancer Res Treat; 2024; 23():15330338241260646. PubMed ID: 38841792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
    Shueng PW; Wu LJ; Chen SY; Hsiao CH; Tien HJ; Cheng PW; Kuo YS; Chen YJ; Chen CA; Hsieh PY; Hsieh CH
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):715-21. PubMed ID: 19879069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer.
    Al-Mamgani A; Levendag PC; van Rooij P; Meeuwis CA; Sewnaik A; Teguh DN
    Head Neck; 2013 Dec; 35(12):1689-97. PubMed ID: 23483648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obtaining normal tissue constraints using intensity modulated radiotherapy (IMRT) in patients with oral cavity, oropharyngeal, and laryngeal carcinoma.
    Skinner WK; Muse ED; Yaparpalvi R; Guha C; Garg MK; Kalnicki S
    Med Dosim; 2009; 34(4):279-84. PubMed ID: 19854386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.
    Teguh DN; Levendag PC; Sewnaik A; Hakkesteegt MM; Noever I; Voet P; van der Est H; Sipkema D; van Rooij P; Baatenburg de Jong RJ; Schmitz PI
    Radiother Oncol; 2008 Oct; 89(1):57-63. PubMed ID: 18722028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial clinical experience with helical tomotherapy for head and neck cancer.
    Chen AM; Jennelle RL; Sreeraman R; Yang CC; Liu T; Vijayakumar S; Purdy JA
    Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
    Stewart AJ; Lee YK; Saran FH
    Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.
    Werbrouck J; De Ruyck K; Duprez F; Veldeman L; Claes K; Van Eijkeren M; Boterberg T; Willems P; Vral A; De Neve W; Thierens H
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1187-95. PubMed ID: 19251090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.